Clinical Trial Update: Vitamin D3 For CGD Patients With BCGosis/Itis [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update reports completion of Phase 2/3 studies evaluating Vitamin D3 for chronic granulomatous disease patients with BCG-related infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Granulomatous Disease

Drugs mentioned

• Vitamin D3 (Cholecalciferol)

Snippet

Sponsor: Children's Hospital of Fudan University | Conditions: Vitamin D3, Chronic-granulomatous Disease | Phase 2, Phase 3 | Status: COMPLETED